Email ID
Password
Sign me in automatically next time
UCB prepares for Cimzia filing in axial spondyloarthritis and psoriatic arthritis

UCB is to make US and EU regulatory submissions for Cimzia (certolizumab pegol) by the end of the year for axial spondyloarthritis (AxSpA) including ankylosing spondylitis (AS), after reporting...
16 April 2012
Pial Ganguli





Please Login to read the full article.
EVENTS
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36